Skip to main content
SpringerLink
Log in

Trastuzumab

Decrease in left ventricular ejection fraction, hypertension and cardiotoxicity: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Rainone R, et al. Measuring adherence to european society of cardiology guidelines for patients treated with trastuzumab. European Journal of Hospital Pharmacy - Science and Practice 26 (Suppl. 1): A228 abstr. 5PSQ-058, 2019. Available from: URL: https://ejhp.bmj.com/content/ejhpharm/26/Suppl_1/A228.1.full.pdf [abstract] - France

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trastuzumab. Reactions Weekly 1761, 356 (2019). https://doi.org/10.1007/s40278-019-64728-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-64728-1

Search

Navigation